Drug Trial Radar · NCT00641745
Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia
Last checked: Nov 20, 2026Latest source record: Jun 22, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
629
Actual
Start
Mar 2008
Primary completion
Jul 2010
Study completion Jul 2010
Sponsor
- Lead sponsor
- Sumitomo Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 24, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is safe and tolerable long term among clinically stable patients. The study will also assess the long term effectiveness of lurasidone as compared to an active comparator.
Conditions
- Schizophrenia
- Schizoaffective Disorder
Interventions
Lurasidone HClDrug
40 - 120mg per day
RisperidoneDrug
Risperidone
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events.Time frame: 12 months
Locations
73 sites in 8 countries. Site status is shown where the registry gives one.
K&S Professional Research Services LLC
Little Rock, Arkansas
Woodland International Research Group, LLC
Little Rock, Arkansas
South Coast Clinical Trials, Inc.
Anaheim, California
Comprehensive NeuroScience, Inc. - Cerritos
Cerritos, California
Clinical Innovations Inc.
Costa Mesa, California
Collaborative Neuroscience Network Inc
Garden Grove, California
University of Southern California
Los Angeles, California
Excell Research
Oceanside, California
University of California at Irvine Medical Center
Orange, California
Pasadena Research Institute
Pasadena, California
CNRI-Los Angeles, LLC
Pico Rivera, California
Clinical Innovations Inc.
Riverside, California
CNRI-San Diego LLC
San Diego, California
UCSD, Outpatient Psychiatric Services
San Diego, California
Clinical Innovations Inc.
Santa Ana, California
Collaborative Neuroscience Network Inc
Torrance, California
Comprehensive NeuroScience, Inc.
Washington D.C., District of Columbia
Fidelity Clinical Research Inc., c/o Segal Institute for Clinical Research
North Miami, Florida
Fidelity Clinical Research Inc.
North Miami, Florida
Atlanta Center for Medical Research
Atlanta, Georgia
Northlake Medical Research Center
Tucker, Georgia
Alexian Brothers Medical Center
Hoffman Estates, Illinois
Lake Charles Clinical Trials
Lake Charles, Louisiana
Sheppard Pratt Health System
Baltimore, Maryland
Precise Research Center
Flowood, Mississippi
St. Charles Psychiatric Associates - Midwest Research
Saint Charles, Missouri
St. Louis Clinical Trials
St Louis, Missouri
Creighton University
Omaha, Nebraska
CRI Worldwide
Willingboro, New Jersey
SUNY Downstate University
Brooklyn, New York
Neurobehavioral Research Inc.
Cedarhurst, New York
Manhattan Psychiatric Center
New York, New York
Social Psychiatry Research Institute
New York, New York
University of North Carolina at Chapel Hill
Raleigh, North Carolina
Keystone Clinical Studies, LLC
Norristown, Pennsylvania
CRI Worldwide
Philadelphia, Pennsylvania
Research Strategies of Memphis LLC
Memphis, Tennessee
Community Clinical Research, Inc.
Austin, Texas
Pillar Clinical Research LLC
Dallas, Texas
Claghorn-Lesem Research Clinic, Inc.
Houston, Texas
Showing 40 of 73 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.